8/28/2020 Survival and health care use after deep brain stimulation for Parkinson’s Disease Crispo JAG, Lam M, Le B, Shariff SZ, Ansell DR, Squarzolo M, Ouellette D, Thibault DP, Marras C, Willis AW, Seitz D. Can J Neurol Sci. 2020; Aug 28 [Epub ahead of print]. DOI: https://doi.org/10.1017/cjn.2020.187
5/15/2020 Beta agonists and progression of Parkinson’s disease in older adults a retrospective cohort study Marras C, Pequeno P, Austin PC, Gershon AS, Iqbal J, Rochon PA, Lang AE. Mov Disord. 2020; 35(7):1275-7. Epub 2020 May 15. DOI: https://doi.org/10.1002/mds.28085
5/14/2020 Identifying drugs with disease‐modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology Maclagan LC, Visanji NP, Cheng Y, Tadrous M, Lacoste AMB, Kalia LV, Bronskill SE, Marras C. Pharmacoepidemiol Drug Saf. 2020; 29(8):864-72. Epub 2020 May 14. DOI: https://doi.org/10.1002/pds.5015